These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1613 related articles for article (PubMed ID: 20933083)

  • 21. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
    Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
    Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme.
    Rawat M; Singh D; Saraf S; Saraf S
    Drug Dev Ind Pharm; 2008 Feb; 34(2):181-8. PubMed ID: 18302037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alginate microparticles as novel carrier for oral insulin delivery.
    Reis CP; Ribeiro AJ; Neufeld RJ; Veiga F
    Biotechnol Bioeng; 2007 Apr; 96(5):977-89. PubMed ID: 17001630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral peptide delivery: in-vitro evaluation of thiolated alginate/poly(acrylic acid) microparticles.
    Greimel A; Werle M; Bernkop-Schnürch A
    J Pharm Pharmacol; 2007 Sep; 59(9):1191-8. PubMed ID: 17883889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres.
    Pan Y; Zheng JM; Zhao HY; Li YJ; Xu H; Wei G
    Acta Pharmacol Sin; 2002 Nov; 23(11):1051-6. PubMed ID: 12421485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
    Reis CP; Ribeiro AJ; Houng S; Veiga F; Neufeld RJ
    Eur J Pharm Sci; 2007 Apr; 30(5):392-7. PubMed ID: 17280820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin encapsulation in reinforced alginate microspheres prepared by internal gelation.
    Silva CM; Ribeiro AJ; Ferreira D; Veiga F
    Eur J Pharm Sci; 2006 Oct; 29(2):148-59. PubMed ID: 16952452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and characterization of an oily-based system for oral delivery of insulin.
    Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity and gut associated lymphoid tissue translocation of polymyxin B orally administered by alginate/chitosan microparticles in rats.
    Coppi G; Bondi M; Coppi A; Rossi T; Sergi S; Iannuccelli V
    J Pharm Pharmacol; 2008 Jan; 60(1):21-6. PubMed ID: 18088501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
    Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
    Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained insulin release with biodegradation of chitosan gel beads prepared by copper ions.
    Kofuji K; Murata Y; Kawashima S
    Int J Pharm; 2005 Oct; 303(1-2):95-103. PubMed ID: 16139972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel biodegradable and pH-sensitive poly(ester amide) microspheres for oral insulin delivery.
    He P; Tang Z; Lin L; Deng M; Pang X; Zhuang X; Chen X
    Macromol Biosci; 2012 Apr; 12(4):547-56. PubMed ID: 22362708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide.
    Sharma VK; Mazumder B
    Int J Biol Macromol; 2014 May; 66():15-25. PubMed ID: 24530641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral delivery of insulin using chitosan capsules cross-linked with phytic acid.
    Lee H; Jeong C; Ghafoor K; Cho S; Park J
    Biomed Mater Eng; 2011; 21(1):25-36. PubMed ID: 21537061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication of flocculation-resistant pH/ionic strength/temperature multiresponsive hollow microspheres and their controlled release.
    Mu B; Liu P; Li X; Du P; Dong Y; Wang Y
    Mol Pharm; 2012 Jan; 9(1):91-101. PubMed ID: 22098247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique.
    Ribeiro AJ; Silva C; Ferreira D; Veiga F
    Eur J Pharm Sci; 2005 May; 25(1):31-40. PubMed ID: 15854798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 81.